[CUSIP No. 74906P1049 13G Page 1 of 9 Pages 1 NAMES OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY): SL Camel Holdco Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY]
[TABLE OF CONTENTS TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED MARCH 31, 2015 Page PART I. Item 1. Business. 4 Item 1A. Risk Factors. 23 Item 1B. Unresolved Staff Comments. 43 Item 2. Properties. 44 Item 3. Legal Proceedings. 44 Item 4. Mine Safety Disclosures. 44 PART II. Item 5. 45 Item 6. Selected Financial Data. 45 Item] [List of Subsidiaries 1. Renovation Investment (Hong Kong) Co., Ltd. (“Renovation”) is a Hong Kong company and is wholly-owned by the Company. 2. Hangzhou Jiutong Medical Technology Co., Ltd. (“Jiutong Medical”) is a Chinese company and is wholly-owned by Renovation. 3. Zhejiang Shouantang Pharmaceutical Technology Co., Ltd. (“Shouantang Technology”) is a Chinese company and is wholly-owned by Renovation. 4. Zhejiang] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements of China Jo-Jo Drugstores, Inc. and its subsidiaries on Form S-3 (No. 333-198001) and Form S-8 (No. 333-171849) of our report dated June 26, 2015 relating to the consolidated financial statements which appear in this Annual Report on Form 10-K. June] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-198001) and Form S-8 (No. 333-171849) of China Jo-Jo Drugstores, Inc. and subsidiaries of our report dated June 27, 2014 relating to the consolidated financial statements, which appear in this Form 10-K. Friedman LLP New York, New] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: (1) I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: (1) I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) June 29,]
[Press Release iKang Announces Acquisition of Two Medical Centers in Yantai Increases Reach of Nationwide Network This acquisition will mark iKangs first foray into Shandong Province, which has a population close to 100 million and built itself as one of the largest economies in China. Hongkang, founded in 2009 with a well-established customer base and excellent medical team, is the] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 Peoples Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]
[China Jo-Jo Drug Stores Announces Fourth Quarter and Year End Financial Results for Fiscal Year 2015 Q4 Revenue grew 30.1%, EPS jumped to $0.03/share from Losses of $1.01/share FY 2015 Online Pharmacy Sales Increased 96.8%, Gross Profit up 117.2% and EPS Improved to $0.06 from Losses of $1.83 HANGZHOU, China, June 29, 2015 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ] []
